Bora Pharmaceuticals CDMO Capabilities Overview

Bora’s CDMO capabilities span the full drug development lifecycle, offering pharmaceutical partners a comprehensive suite of services from early formulation through commercial-scale production. With facilities across Asia and North America, Bora delivers development, manufacturing, analytical testing, and packaging for diverse dosage forms, including oral solids, liquids, semi-solids, biologics, and sterile injectables.

The organization combines technical expertise with global regulatory compliance, ensuring projects meet stringent cGMP standards while accelerating timelines for both clinical and commercial programs. Its integrated approach and operational scale enable flexibility for complex projects, helping partners bring high-quality therapeutics to market efficiently.

This overview provides insight into how advanced infrastructure, specialized teams, and a global footprint position Bora as a trusted partner for pharmaceutical innovators seeking speed, reliability, and precision in drug development and manufacturing.